Chapter
Vitamin D Analogues: Potential Inhibitors of Vitamin D Metabolism
pp.:
52 – 62
Synthesis of 26,27-Hexadeutero and Epimeric 26-Trideutero 1,25-Dihydroxycholecalciferols
pp.:
62 – 65
Chemical Synthesis of Vitamin D Analogs with Selective Biological Activities
pp.:
65 – 74
Chemistry of Vitamin D, its Metabolites and Analogs
pp.:
74 – 83
A Practical Synthesis of 1-Alpha-OH Vitamin D3 Analogs
pp.:
83 – 91
Synthesis of Biologically Active Cyclopropane Analogues of 1α, 25-Dihydroxy- and 1α-Hydroxy-Vitamin D3
pp.:
91 – 93
Asymmetric Synthesis of 1α, 25-Dihydroxyvitamin D3 and Analogs
pp.:
93 – 94
Chemical Synthesis and Studies of 9(11)-Dehydrovitamin D and its 11-Substituted Analogues
pp.:
94 – 98
A- and C-Ring Modified Vitamin D Analogues: A Mechanistic Study of the [1,7]-Sigmatropic Hydrogen Shift of the Previtamin D-Vitamin D Equilibrium
pp.:
98 – 100
Synthesis and Biologic Evaluation of a Second Generation Photoaffinity Analog of 1,25-Dihydroxyvitamin D3
pp.:
100 – 102
Synthesis of the Unnatural (7Z)-Vitamin D Triene System
pp.:
102 – 104
Novel and Stereoselective Syntheses of 1α-Hydroxylated Vitamin D Metabolites
pp.:
104 – 106
On Oxidation of the Vitamin D Triene System – A Simple and Convenient Entry into the 19-Nor-10-Oxo-Derivatives of Vitamin D
pp.:
106 – 108
Synthesis of 25-Hydroxydihydrotachysterol2
pp.:
108 – 110
Stereochemistry at C(23) of 23,25-Dihydroxy-24-Oxovitamin D3
pp.:
110 – 112
Synthesis and Biological Activity of Highly Active Vitamin D Analogs: General Approaches to the Synthesis of Biologically Potent Vitamin D Sterols
pp.:
112 – 114
Syntheses of Labeled Side Chains of Vitamin D Metabolites and Analogs
pp.:
114 – 116
Synthesis of 22-Oxa-, and 20-Oxa-Analogues of Vitamin D3
pp.:
116 – 118
Computer Calculations of the Active Conformation of 1,25-Dihydroxy Vitamin D3
pp.:
118 – 121
Vitamin D Metabolism and Catabolism
pp.:
121 – 123
Precholecalciferol Formation by an Invertebrate, Psammechinus Miliaris
pp.:
123 – 133
Species Variation of Vitamin D Metabolism and Action: Lessons to be Learned from Farm Animals
pp.:
133 – 142
Metabolism of Vitamin D in Phagocytic Cells
pp.:
142 – 152
Extrarenal Production of Calcitriol in Chronic Renal Failure
pp.:
152 – 154
Metabolism of 1,25(OH)2D3 in Perfused Duodena from Normal Chicks
pp.:
154 – 156
Intestinal Metabolism of 25-Hydroxyvitamin D3: Effect of the X-Linked Hyp Mutation and 1,25-Dihydroxyvitamin D3 Treatment
pp.:
156 – 158
Biosynthesis of Water-Soluble Metabolites of 1,25-Dihydroxyvitamin D3 by Osteosarcoma UMR-106
pp.:
158 – 160
Conversion of 25-Hydroxyvitamin D3 to 19-Nor-10-Oxo-25-Hydroxyvitamin D3 by Solubilized Chick Kidney Mitochondria and Bovine Serum Albumin
pp.:
160 – 162
24-Oxidation of 1,25-(OH)2D3 by a Human Osteosarcoma Cell Line, U-20S
pp.:
162 – 164
The Vitamin D Depletion of Chronic Cholestasis is Independent of the Hepatic Metabolism of Vitamin D3
pp.:
164 – 166
Metabolic Clearance Rate and Production Rate of Calcitriol in Uremia. Effects of 25(OH)D Therapy
pp.:
166 – 168
Measurement of Production Rate and Metabolic Clearance Rate of 1,25- Dihydroxyvitamin D3 in Conscious Rats Using a Simplified Primed-Infusion Technique
pp.:
168 – 170
Metabolism of 1,25(OH)2D3 after Consecutive Dose of 1αOHD3 and 1,25(OH)2D3 in Rats
pp.:
170 – 172
25-Hydroxyvitamin D3 Sulphate in Human Plasma: Observations Using High Performance-Liquid Chromatography and Gas Chromatography-Mass Spectrometry
pp.:
172 – 175
The Effect of Vitamin D Status of Vitamin D Metabolism in Chicks
pp.:
175 – 177
Identification of a Subset of Dairy Cows that Fail to Produce 1,25-Dihydroxyvitamin D (1,25-(OH)2D) at the Onset of the Hypocalcemia Associated with Parturient Paresis
pp.:
177 – 179
The Intact Hepatocyte Hypothesis Applies to the C-25 Hydroxylation of Vitamin D3 in Alcoholic Cirrhosis
pp.:
179 – 181
Mechanism of Action of 26,27-Hexafluoro-1,25(OH)2D3
pp.:
181 – 183
1α, 25(OH)2D3-26,23-Lactone is a Major Metabolite of 1α, 25(OH)2D3 under Physiological Conditions
pp.:
183 – 185
25-Hydroxy-24-Oxovitamin D3 is a Natural Metabolite under Physiological Conditions
pp.:
185 – 187
Metabolism of 1,25(OH)2D3 after Single Intravenous or Oral Dose of 1αOHD3 and 1,25(OH)2D3 In Rats
pp.:
187 – 189
Administration of Pharmacological Amounts of 25(S), 26-Dihydroxyvitamin D3 Reduces 1,25-Dihydroxyvitamin D3 Synthesis
pp.:
189 – 191
The Effect of Growth Hormone on the Phosphate and Calcitriol Responses to Dietary Phosphorus Restriction in Man
pp.:
191 – 193
The Effect of Glutethimide on Rapidly Reducing the Circulating Concentration of 1,25-Dihydroxy Vitamin D in Hypervitaminosis D
pp.:
193 – 195
Biochemistry and Regulation of Hydroxylases
pp.:
195 – 197
Current Models for the Study of the Regulation of 25(OH)D3 Metabolism
pp.:
197 – 206
Solubilization and Reconstitution of Mammalian 25-OH-Vitamin D3-24 and 1α-Hydroxylase Activities from Pig Mitochondria
pp.:
206 – 208
Molecular Characterization of the Iron-Sulfur Protein from the Porcine Kidney Mitochondrial Hydroxylase System
pp.:
208 – 210
Normal Regulation of Calcitriol Production in Gy-Mice: Evidence for Biochemical Heterogeneity in the X-Linked Hypophosphatemic Diseases
pp.:
210 – 212
Regulation of 25-Hydroxyvitamin D3 Metabolism in Mitochondria Isolated from Primary Cultures of Chick Kidney Cells: Effects of Parathyroid Hormone and Forskolin
pp.:
212 – 214
The Stimulation of 25-Hydroxyvitamin D-1-Hydroxylase by Dietary Phosphorus Restriction Requires Insulin-Like Growth Factor-I (IGF-I)
pp.:
214 – 217
Phorbolic Ester Effect on Rat Renal 25-OHD3 1-Hydroxylase Activity: Possible Role of Ca, Phospholipid-Dependent Proteinkinase
pp.:
217 – 219
In Vitro Measurement of 25-Hydroxyvitamin D-1-Hydroxylase (1-OHase) Activity in Lactating Mice Using a New, Commercially Available Assay
pp.:
219 – 221
Inhibition of Renal Mitochondrial 25(OH)D-1-Hydroxylase Activity by Phosphorylation of Ferredoxin
pp.:
221 – 223
Protocol for Partial Purification of the Cytochrome P-450-1α
pp.:
223 – 225
Purification of a Cytochrome P-450 from Rabbit Liver Mitochondria Catalyzing 25-Hydroxylation of Vitamin D3
pp.:
225 – 227
Acute Changes in Perfusate Calcium and Phosphorus do not Affect 1-α-Hydroxylase Activity in the Isolated Perfused Rat Kidney
pp.:
227 – 229
Does the Administration of Phosphate Increase the Serum 1,25(OH)2D Concentration in X-Linked Hypophosphatemic Rickets?
pp.:
229 – 231
Ascorbic Acid Effects on 1-OHase and 24-OHase Activity in Kidney and 1,25(OH)2D3 Receptor Binding in Intestinal Mucosa of Guinea-Pigs
pp.:
231 – 234
Metabolism in Vitro of 25-Hydroxyvitamin D3 by Cultured Porcine Alveolar Macrophages
pp.:
234 – 236
Evidence that Rat Kidney 25-Hydroxyvitamin D-24-Hydroxylase Can Exist in an Inactive State
pp.:
236 – 238
25 Hydroxyvitamin D, 1α Hydroxylase (1-OH-Lase) Activity in Rhesus Monkeys
pp.:
238 – 240
25-Hydroxylation of Vitamin D3 by a Cytochrome P-450 from Pig Kidney Microsomes
pp.:
240 – 243
Receptors for 1,25(OH)2D3 (Biochemistry and Molecular Biology)
pp.:
243 – 245
Vitamin D Hormone Receptors: Structure, Regulation and Molecular Function
pp.:
245 – 255
Vitamin D3 Receptors: Molecular Structure of the Protein and its Chromosomal Gene
pp.:
255 – 265
Definition of the Funktional Domains of the Vitamin D3 Receptor
pp.:
265 – 267
Hyperthyroidism Increases Nuclear 1,25-Dihydroxyvitamin D3 Binding in Female Rat Liver
pp.:
267 – 269
Changes in Intestinal 1,25-Dihydroxyvitamin D Receptor Durning Aging, Gestation and Pregnancy in Rats
pp.:
269 – 271
Positive Cooperativity of the Rat Intestinal 1,25 Dihydroxyvitamin D Receptor
pp.:
271 – 273
Ketoconazole Potentiates 1,25-(OH)2D3-Directed Upregulation of 1,25-(OH)2D3-Receptors in Rat Intestine and Bone
pp.:
273 – 275
1α, 25-Dihydroxyvitamin D3 Receptor Defects in Lymphocyte Cell Lines from Vitamin D-Dependent Rickets Type II
pp.:
275 – 277
Vitamin K Role in the Interaction of 1,25(OH)2D3 Receptors with DNA
pp.:
277 – 280
Administration of 1,25-Dihydroxyvitamin D3 (1,25-(OH)2D3) Upregulates Number of Receptors for 1,25-(OH)2D in Colon Mucosa of Dairy Cows
pp.:
280 – 282
Characterization of the Chromosomal Gene of the Mouse Vitamin D Receptor
pp.:
282 – 284
Regulation of Vitamin D Action in Rat Osteogenic Sarcoma Cells (UMR-106)
pp.:
284 – 286
Duodenum and Colon 1,25-Dihydroxyvitamin D (1,25-(OH)2D) Receptor Concentration is Increased During Lactation in the Rat
pp.:
286 – 288
The 1,25-Dihydroxycholecalciferol Level in Plasma does not Influence the Properties of its Intestinal Receptor in Piglets
pp.:
288 – 290
The Number of 1,25-Dihydroxyvitamin D Receptors in Rat Intestinal Mucosa have been Markedly Underestimated
pp.:
290 – 296
DNA Binding Property of Vitamin D3 Receptors Associated with 26,26,26,27,27,27-Hexafluoro-1,25(OH)2D3
pp.:
296 – 298
Vitamin D3 Binding Protein of Phaseolus Vulgaris Roots. Biochemical and Functional Characterization
pp.:
298 – 301
Cell Differentiation / Hematopoiesis / Immunology
pp.:
301 – 303
Interaction between the Hematopoietic System and the Vitamin D Endocrine System
pp.:
303 – 307
1,25-(OH)2D3 and Gene Expression During HL-60 Differentiation
pp.:
307 – 316
Vitamin D: A Steroid Hormone of the Immune System, by the Immune System, for the Immune System
pp.:
316 – 322
Immunoregulatory Properties of 1,25(OH)2D3: Cellular Requirements and Mechanisms
pp.:
322 – 331
1,25-Dihydroxyvitamin D3 and the Regulation of Cancer Cell Replication
pp.:
331 – 340
MC 903 – A Novel Vitamin D Analogue with Potent Effects on Cell Proliferation and Cell Differentiation
pp.:
340 – 350
1α, 25-Dihydroxy-22-Oxavitamin D3: A New Synthetic Analogue of Vitamin D3 Having Potent Differentiation-Inducing Activity without Inducing Hypercalcemia in Vivo and in Vitro
pp.:
350 – 360
Mechanisms of Cell Fusion Induced by 1α,25-Dihydroxyvitamin D3
pp.:
360 – 370
1,25(OH)2D3 Promotes Differentiation of Resting Chondrocytes to Hypertrophic Cells in Vitro: A Model System for Evaluating the Potency of Vitamin D Analogs
pp.:
370 – 372
1α,25-Dihydroxyvitamin D3 Synthesis by Synovial Fluid Macrophages in Arthritic Disease
pp.:
372 – 374
1,25-Dihydroxyvitamin-D3 Prolongs Rat Cardiac Allograft Survival
pp.:
374 – 376
1,25-Dihydroxyvitamin D3 as a Synergistic Agent of in Vitro Cyclosporin A-Induced Suppressive Activity in Rheumatoid Arthritis
pp.:
376 – 378
Changes in Phosphoinositide Metabolism During 1,25(OH)2D3 Induced Cell Differentiation
pp.:
378 – 380
Increase in [Ca2+]i in Cultured Human Keratinocytes by 1,25(OH)2D3 is Calcium Dependent and Coincides with an Increase in Phosphatidylinositol Metabolism
pp.:
380 – 382
The Effects of 1α,25(OH)2D3, Diltiazem (D-Cis, L-Cis) on Induction of Differentiation of HL-60 Cells
pp.:
382 – 384
1α-Hydroxylated Vitamin D Metabolites Promote Differentiation and 24,25-Dihydroxy Vitamin D Synthesis in Human Leukaemia (HL60) Cells
pp.:
384 – 386
1,25 Dihydroxyvitamin-D3 Prolongs Skin Graft Survival in Mice
pp.:
386 – 388
Effects of 1,25(OH)2D3 on Myelopoiesis and B Lymphopoiesis in Long-term Marrow Cultures
pp.:
388 – 390
Vitamin D-Deficiency Disturbs the Differentiation Process in the Dental Papilla: An Ultrastructural Study
pp.:
390 – 392
1,25-Dihydroxyvitamin D3 Inhibits Delayed-Type Hypersensitivity Mediated by T-Cell Clones Inducing Experimental Autoimmune Encephalomyelitis
pp.:
392 – 394
1,25-Dihydroxyvitamin D3 Acts Directly on Human Lymphocytes and Interferes with the Cellular Response to Interleukin-2
pp.:
394 – 396
1α,25-Dihydroxyvitamin D3 Synthesis by Normal and Myelofibrotic Human Spleen Cells
pp.:
396 – 398
Pretreatment of T Cell or Monocytic Cell Lines with 1,25(OH)2D3 Markedly Increases IL2 or IL1 mRNA Levels Following Cell Activation
pp.:
398 – 400
Phorbol Ester Stimulation of 25OH-Vitamin D 1-Hydroxylase Activity in the Monoblastic Cell Line U937
pp.:
400 – 402
An Evaluation of Analogs of 1,25-Dihydroxyvitamin D3 on the Inhibition of Proliferation and Induction of Terminal Differentiation in Cultured Human Normal Keratinocytes
pp.:
402 – 404
1,25-Dihydroxyvitamin D3 Potentiates the Immunomodulatory Action of Prostaglandin E2 and Histamine by Interacting with cAMP-Dependent Pathways
pp.:
404 – 406
Effects of 1,25-Dihydroxyvitamin D3 and other Steroid Hormones on Protein Syntheses in Primary Cultures of Adult Rat Hepatocytes
pp.:
406 – 408
The Separation of Keratinocyte Populations Using a Gravity Sedimentation Chamber: A Potential Tool for the Study of 1,25(OH)2D3 Action on Cells at Different Stages of Differentiation
pp.:
408 – 410
Evidence that Osteoinduction by Implants of Demineralized Allogenic Bone Matrix is Diminished in Vitamin D-Deficient Normocalcemic Rats R. T. Turner, J. J. Vandersteenhoven, ?. H. Bell
pp.:
410 – 412
1,25(OH)2D3 Binds Specifically to Rat Vascular Smooth Muscle Cells and Stimulates their Proliferation in Vitro
pp.:
412 – 414
Involvement of Intracellular Free Calcium and pH in the Effect of 1,25(OH)2D3 on Leukemic Cells
pp.:
414 – 417
Gene Regulation by 1,25(OH)2D3
pp.:
417 – 419
Modifications in the Interactions of Regulatory Proteins with the Promoter of a Cell Growth Regulated Gene Induced to Differentiate by 1,25(OH)2D3
pp.:
419 – 421
Inhibition of 1,25-Dihydroxyvitamin D3 Stimulated BGP mRNA Synthesis in ROS 17/2 Cells after Prolonged Treatment with 1,25-Dihydroxyvitamin D3
pp.:
421 – 423
1,25(OH)2D Regulates Oncogene Expression in U937 Cells
pp.:
423 – 425
Regulation of Calbindin-D9K (CaBP9K) Gene Expression by 1,25-Dihydroxycholecalciferol and Calcium in Organ Cultures of Fetal Rat Duodenum
pp.:
425 – 427
Enhancement of the Genomic Action of 1,25-Dihydroxycholecalciferol by Triiodothyronine is a Regulatory Factor of Intestinal Calcium and Phosphate Transport
pp.:
427 – 429
Influence of Vitamin D3 upon the Expression of PEP-19, a Putative Neuron-Specific Calcium-Binding Protein
pp.:
429 – 431
Induction of Osteocalcin Synthesis in Human Osteosarcoma Cells by 1,25-Dihydroxyvitamin D and 24,24-Difluoro-1,25-Dihydroxyvitamin D
pp.:
431 – 433
Biological Actions of Vitamin D Metabolites
pp.:
433 – 435
The Role of 24,25 Dihydroxy Vitamin D3 During Development of Skeletal and Non-Skeletal Tissues
pp.:
435 – 445
The Regulation of Intracellular Ionized Calcium by Calcitriol
pp.:
445 – 456
Rapid Action of 1,25(OH)2D3 in Liver Cells
pp.:
456 – 459
1,25(OH)2D3 directly Modulates Human Melanocyte Function
pp.:
459 – 461
Stimulation of Synthesis of Myoblast Membrane Proteins by 25-Hydroxy- Vitamin D3
pp.:
461 – 463
Stimulation of Rat Duodenal Brush Border Alkaline Phosphatase Activity within 10 Minutes of in Vivo Calcitriol Administration
pp.:
463 – 465
1,25-Dihydroxy-Vitamin D3 Increases 3H-Thymidine-Uptake and Potentiates the Effect of Epidermal Growth Factor in FRTL-5 Cells
pp.:
465 – 467
1,25-Dihydroxyvitamin D3 Stimulates 45Ca2+ Uptake by Cultured Vascular Smooth Muscle Cells Derived from Rat Aorta
pp.:
467 – 469
1,25(OH)2D3 Activates Protein Kinase C in Rat Colonic Crypts
pp.:
469 – 471
Free 1,25-Dihydroxyvitamin D3 Levels in Normal and Rachitic Piglets
pp.:
471 – 473
1,25(OH)2 Vitamin D3 Analogs: Comparison of 1,25(OH)2D3 Receptor Ligand Specificity and Biological Activity in the Chick and Human Promyelocyte (HL-60) Cells
pp.:
473 – 475
24,25-Dihydroxy-Vitamin D3 Binding in Bovine Thyroid
pp.:
475 – 477
Effects of 1,25-Dihydroxy-Vitamin D3 on Phospholipid Metabolism in Cultured Myoblasts
pp.:
477 – 479
Vitamin D Status and Intestinal Absorption of Aluminum in Rats with Normal or Reduced Renal Function
pp.:
479 – 481
Direct Effect of Vitamin D Metabolites on Matrix Vesicle Alkaline Phosphatase
pp.:
481 – 483
Proliferative Effects of 1,25-Dihydrocholecalciferol (1,25-DHCC), 24,25-Dihydroxycholecalciferol (24,25-DHCC), 25-Hydroxycholecalciferol (25-HCC) and 1α-Hydroxycholecalciferol (1α-HCC)
pp.:
483 – 485
The Effect of Pertussis Toxin on PTH- and 1α,25(OH)2D3-Induced Desensitization in Rat Osteoblasts of the cAMP Response to PTH
pp.:
485 – 488
Synergistic Effects of Vitamin D3 Metabolites
pp.:
488 – 490
25(OH)D3, but not 1,25(OH)2D3 Cures Osteomalacia in Marmoset Monkeys
pp.:
490 – 492
Acute Release of Bioactive PTH by Intravenous 1,25 Dihydrocholecalciferol in Chronic Renal Failure
pp.:
492 – 494
1,25-Dihydroxy-Vitamin D3 Increases Calmodulin Binding to Skeletal Muscle Membrane Proteins
pp.:
494 – 496
Hypoparathyroidism in Hereditary Resistance to 1,25(OH)2D During Long-Term Treatment with Excessive Doses of Vitamin D3
pp.:
496 – 498
Effects of 1-alpha-OHD3 in Intestinal Radiocalcium Absorption and Serum Bone GLA Protein in Normal Subjects and Osteoporotic Women R. Nuti, V. Turchetti, G. Martini, G. Righi, F. Loré, A. Caniggia
pp.:
498 – 500
Rapid Effects of 1,25(OH)2-Vitamin D3 on Calcium Uptake by Cardiac Muscle
pp.:
500 – 502
1α, 25-Dihydroxyvitamin D3 in Rat Skin: Identification, Quantification and Biological Function
pp.:
502 – 504
1,25-Dihydroxyvitamin D3 Stimulates Ca-ATPase and Regulates Cellular Calcium in Vascular Smoosth Muscle Cells
pp.:
504 – 507
Calbindins (Biochemistry, Molecular Biology, Biological Actions)
pp.:
507 – 509
Calbindin-D9K (CaBP9K) Gene: Expression, Regulation, Structure and Evolution
pp.:
509 – 519
1,25-Dihydroxyvitamin D3, its Receptor and the Eukaryotic Genome
pp.:
519 – 529
Structure and Evolution of the Chick Calbindin Gene
pp.:
529 – 539
Regulation of Rat Calbindin-D28k Gene Expression
pp.:
539 – 547
Molecular Cloning and Sequencing of Calbindin-D9K cDNA from Mouse Placenta
pp.:
547 – 549
High Conservation of Calbindin D28 in Evolution: Implications for its Function
pp.:
549 – 552
Functional Analysis of the Promotor Region of the Gene Encoding Chicken Calbindin-D28K
pp.:
552 – 554
Cellular Localization of Brain Calbindin-D28k
pp.:
554 – 556
Vitamin D Dependence of Calbindin D 9K and Calbindin D 28K Synthesis in Various Rat Tissues
pp.:
556 – 558
Immunohistochemical Demonstration of Vitamin D-Dependent Calcium-Binding Protein, Calbindin-D 28K (CaBP28K) in the Spinal Cord Motoneurons of Teleost Fish
pp.:
558 – 560
In Situ Hybridization of the Rat Calbindin D-28
pp.:
560 – 563
Spectroscopic Studies on Chick Intestinal Calbindin-D28K Suggest the Existence of 4-6 Functional Ca2+ Binding Sites
pp.:
563 – 565
Evolution of the “EF-Hand” CaBP Family: Exon Shuffling and Intron Insertion
pp.:
565 – 567
Effects of Altered Thyroid States and Undernutrition on Calbindin-D28K (Calcium-Binding Protein) in the Hippocampal Formation of the Developing Rat
pp.:
567 – 569
Expression of Calbindin D Decreases with Age in Intestine and Kidney
pp.:
569 – 571
Evidence for Tissue-Specific Regulation of Calbindin 28K Gene Expression in the Chick by 1,25-Dihydroxyvitamin D3
pp.:
571 – 573
Evidence for the Presence of two Vitamin D-Dependent Calcium Binding Proteins in Brain
pp.:
573 – 575
The Human Calbindin D28 Gene
pp.:
575 – 577
Effect of Vitamin D Deficiency and 1,25-Dihydroxycholecalciferol Treatment on Epidermal Calcium Binding Protein (ECaBP) RNA Activity
pp.:
577 – 579
Complete Amino Acid Sequences of Mouse Calbindin-D9K Isoforms Determined by Tandem Mass Spectrometry: Protein Modification by Internal Insertion of a Single Amino Acid
pp.:
579 – 581
Developmental Pattern and Vitamin D-Dependency of the Calbindins CaBP 9KDa and CaBP 28KDa in the Ameloblasts of Rodent Teeth: An Immunocytochemical Study
pp.:
581 – 583
Calbindin (CaBP28kDa) Localization in the Peripheral Vestibular System of Various Vertebrates and Comparison with its Distribution During Development of the Mouse and Human
pp.:
583 – 585
Nuclear Magnetic Resonance and Terbium Fluorescence Studies on the Vitamin D-Dependent 28-Kilodalton Chick Intestinal Calcium-Binding Protein : Evidence for Calcium-Dependent Conformational Change
pp.:
585 – 587
Intestinal and Renal Ca and P Transport
pp.:
587 – 589
Transcaltachia, Vesicular Calcium Transport, and Microtubule-Associated Calbindin-D28K
pp.:
589 – 598
Vitamin D: Effects on Intestinal Calcium Absorption and Peripheral Nerve Function
pp.:
598 – 605
ATP-Dependent Ca2+ Pumps in Endoplasmic Reticulum and Plasma Membranes are not Affected by 9kDa Calbindin-D and Vit. D-Deficiency
pp.:
605 – 607
Effects of Vitamin D-Deficiency on Different Activities of the Ca2+-Pump in Rat Intestinal Basolateral Membranes
pp.:
607 – 609
ATP-Driven Ca2+ Pumps in Duodenal Plasma Membranes and Endoplasmic Reticulum from Piglets with Inherited Rickets
pp.:
609 – 611
Effect of 1,25(OH)2D3 on Phosphorus Absorption in Sheep
pp.:
611 – 613
Reduced Calcium Absorption in X-Linked Hypophosphatemic Rickets
pp.:
613 – 615
Phosphate Transport in the Intestine of the Rat During Early Development: Role of Vitamin D
pp.:
615 – 617
The 105kD Calmodulin (CAM) Binding Protein from Intestinal Brush Border Membrane (BBM) is a Calcium Transport Protein
pp.:
617 – 619
Bone and Action of Vitamin D Metabolites
pp.:
619 – 621
The Role of 1,25-Dihydroxyvitamin D3 in the Generation and Regulation of Osteoclasts
pp.:
621 – 631
Vitamin D and Osteoclastogenesis
pp.:
631 – 636
Dentin Formation and Plasma Ca Levels in PTX Rats given 1,25(OH)2D3
pp.:
636 – 638
Elevated 1,25-Dihydroxyvitamin D3 and Intestinal Calbindin-D9K Levels in the Osteopetrotic Toothless Rat
pp.:
638 – 640
Influence of 24-Fluorinated Analogues of 1,25(OH)2D3 on Bone Matrix Formation and Bone Resorption in Vitro
pp.:
640 – 642
Modulation of the Action of 1,25(OH)2D3 on the Osteocalcin Production of Human Osteoblast-Like Cells by Agents Affecting Adenylate Cyclase Activity
pp.:
642 – 644
Increased Bone Minerals in Vitamin D-Replete Rabbit by the Massive Administration of 24R,25(OH)2D3
pp.:
644 – 646
Studies on the Interactions between Retinoic Acid and 1,25(OH)2D3 on Human Bone-Derived Osteoblast-Like Cells
pp.:
646 – 648
Immunosuppressive Agent Cyclosporin A and Various Cell Growth Factors Affect Cloned Osteoblastic Cell Line MC3T3-E1 Cells
pp.:
648 – 650
23(S)25(R)-1,25(OH)2D3-26,23-Lactone Stimulates Bone Formation in Vivo
pp.:
650 – 652
Side Chain Modifications Increase the Potency of 1,25-Dihydroxy- cholecalciferol (Calcitriol) on Human Bone-Derived Osteoblast-Like Cells
pp.:
652 – 654
Activity of Ornithine Decarboxylase in Hard Tissue of Vitamin D-Deficient and -Replete Rats: Effect of 1,25(OH)2D3, Uremia and Aluminum Intoxication
pp.:
654 – 656
Production of Bone-Resorbing and Osteoclast-Inducing Factors by Osteoblasts in Organ Culture and Modulation by 1,25(OH)2D3 and other Agonists
pp.:
656 – 658
Circulating Osteocalcin in Magnesium Deficiency: Response to 1,25(OH)2D
pp.:
658 – 660
1,25(OH)2D3 Mediates the Effect of Parathyroid Hormone on New Bone Formation in the Rat
pp.:
660 – 662
Circulating Osteocalcin and 1,25-Dihydroxyvitamin D Concentrations and Urinary γ-Carboxyglutamic Acid in Healthy Subjects and in Patients with Metabolic Bone Disease
pp.:
662 – 664
Regulation of Fibronectin and Collagen Synthesis by 1,25-Dihydroxyvitamin D3
pp.:
664 – 666
1,25-Dihydroxyvitamin D3 Stimulates in Vitro Growth of Avian and Mammalian Cartilage
pp.:
666 – 669
Nutritional Aspects of Vitamin D
pp.:
669 – 671
Minimal Intravenous Vitamin D Requirement During Parenteral Nutrition in Infancy
pp.:
671 – 673
Serum 25(OH)D3 and 1,25(OH)2D3 Levels in Wild and Laboratory-Bred Wood Mice and Bank Voles
pp.:
673 – 675
Effect of Acute Ethanol Administration on the Circulating Parameters of Bone Mineral Metabolism
pp.:
675 – 677
Plasma 25-OHvitamin D and PTH in the Detection of Osteomalacia in Asian Outpatients
pp.:
677 – 680
The Vitamin D Content of Finnish Hospital Diets
pp.:
680 – 682
Zinc, Vitamin D and Bone Mass in the Elderly
pp.:
682 – 684
The Importance of Vitamin C for Hydroxylation of Vitamin D3 to 1α,25(OH)2D3 and of 24R,25(OH)2D3 to a More Active Metabolite
pp.:
684 – 694
Plasma Magnesium in Pigs with Pseudo Vitamin D Deficient Rickets; Type 1
pp.:
694 – 696
Sunlight Degradation of Vitamin D3
pp.:
696 – 698
Fatty Acid and Calcium Absorption in Rats. Role of Vitamin D
pp.:
698 – 700
Clinical Studies on the Mechanism of Acquired Vitamin D Deficiency
pp.:
700 – 702
How is Plasma 1,25(OH)2D3 Concentration Regulated by Dietary Calcium?
pp.:
702 – 704
Studies of Rickets and its Prevention in Beijing, China
pp.:
704 – 707
Vitamin D Binding Proteins
pp.:
707 – 709
DBP and AIDS: Fact or Fiction?
pp.:
709 – 714
Plasma Vitamin D Binding Protein: Plasma Scavenger Function and Origin of Cell-Surface DBP
pp.:
714 – 720
Partial Structure of the Gene for Human Vitamin D-Binding Protein
pp.:
720 – 725
A New Interaction between Gc (Vitamin D-Binding Protein) and Unsaturated Fatty Acids
pp.:
725 – 732
Two 25-Hydroxycholecalciferol-Binding Proteins in Carp Serum
pp.:
732 – 734
HPLC Analysis of the Cyanogen Bromide Digest of Human Serum Vitamin D Binding Protein Photoaffinity Labelled with a 25-Hydroxyvitamin D3 Analog
pp.:
734 – 736
Effect of Calcium Ions upon Interactions between Gc (Vitamin D-Binding) Protein and Cibacron Blue
pp.:
736 – 738
Partial Purification and Properties of Bat Vitamin D Binding Protein Meropi Cavaleros
pp.:
738 – 741
Assay Methodology: Vitamin D and Metabolites
pp.:
741 – 743
Measurement of Free Vitamin D Metabolite Levels: Biological and Clinical Significance
pp.:
743 – 750
The Assay of Circulating 1,25(OH)2D using Non-End-Capped C18 Silica (C18-OH): Performance and Validation
pp.:
750 – 760
Simplified Assays for the Determination of 25-OHD, 24,25(OH)2D and 1,25(OH)2D
pp.:
760 – 767
Stable Isotope Dilution Mass Fragmentography for the Measurement of Metabolites of Vitamins D2 and D3 in Human Plasma
pp.:
767 – 768
Well Established Physiological Functions are a Prequisite for Introducing Biochemical Parameters
pp.:
768 – 770
The Quantification of Serum 25-Hydroxyvitamin D Using a Competitive Protein-Binding Assay after Preliminary Purification
pp.:
770 – 772
Changes in Plasma Levels of Vitamin D2, D3 and Their Metabolites after Oral Administration of the Vitamins to Vitamin D-Deficient Rats
pp.:
772 – 774
Age-Related Changes in Immunoradiometric PTH and 25-Hydroxy- vitamin D
pp.:
774 – 775
Relevance of Long-Term Variation in Vitamin D Metabolite Measurements. Implications for Longitudinal Study Design
pp.:
775 – 777
Other Basic Science Topics
pp.:
777 – 779
Prospects for the Modelling of Vitamin D Activity in Man
pp.:
779 – 789
Isolated Rat Proximal Tubule Cell (PTC) Cultures are cAMP Responsive to Parathyroid Hormone (PTH), Calcitonin (CT), and Prostaglandins (PGE) but not to Vasopressin (VP)
pp.:
789 – 791
Lipid Composition of Basolateral Membranes from Rat Enterocytes: Effects of Vitamin D Deficiency
pp.:
791 – 793
Possible Origin of Extremely Large Amounts of Vitamin D3 in Some Kinds of Fish Liver
pp.:
793 – 795
Hepatotoxic Effects of Aluminium: Implications for Vitamin D Metabolism
pp.:
795 – 797
Studies on Kinetics of Previtamin D Formation Reaction, Effects of Irradiation Intensity at 296nm on Previtamin D Formation Zhiren Lu, Yafang Pang, Chengfa Zheng
pp.:
797 – 800
Vitamin D Deficiency and Cardiac Function in Isolated Chick Hearts
pp.:
800 – 802
Vitamin D Effects on Ca-Stimulated ATPase Activity and Protein Composition of the Rat’s Skeletal Muscle Miofibrills
pp.:
802 – 803
The Spontaneously Hypertensive Rat (SHR): A Model of Abnormal Vitamin D Metabolism
pp.:
803 – 805
Vitamin D3- and Stigmasterol-Induced Calmodulin Synthesis in Phaseolus Vulgaris Roots is Mediated by Ca+2 and Plant Growth Hormone-Like Mitogenic Stimulation
pp.:
805 – 807
A Very Rapid Receptor Mediated Action of 1,25-Dihydroxyvitamin D3: Increase of Intracellular Cyclic GMP in Human Skin Fibroblasts
pp.:
807 – 809
Effects of Vitamin D3 Metabolites on Cytosolic Free Calcium in Confluent Mouse Osteoblasts: A Possible Involvement of Protein Kinase C Michèle Lieberherr
pp.:
809 – 819
Renal Osteodystrophy
pp.:
819 – 821
Plasma Kinetics of Intravenous Calcitriol in Normal and Dialysed Subjects and Acute Effect on Serum nPTH Levels
pp.:
821 – 823
Bioavailability of Calcitriol after Oral, Intravenous and Intraperitioneal Doses in Dialysis Patients
pp.:
823 – 825
Intravenous Administration of 1α-Hydroxycholecalciferol in Haemodialysed Patients: Dose-Dependent Increase in Circulating 1,25-Dihydroxycholecalciferol
pp.:
825 – 827
Ten Years Experience in the Prevention of Renal Osteodystrophy by Vitamin D-Prophylaxis
pp.:
827 – 829
Successful Treatment of Renal Osteodystrophy with Keto Acids (KA) and Vitamin D
pp.:
829 – 831
Effect of 1,25(OH)2D3 and 24R,25(OH)2D3 on the Accumulation of Aluminum in Bone in Rats with Renal Failure
pp.:
831 – 833
The Influence of Vitamins D2 and D3 on Intestinal Calcium Absorption in Patients with Renal Insufficiency and in Dialysis Patients
pp.:
833 – 835
1α(OH)D3 i.v. Suppression of PTH Secretion in Hemodialysis Patients
pp.:
835 – 837
Clinical and Biochemical Effects of 1,25-Dihydroxyvitamin D3 Administration in Normal and Renal Impaired Dogs
pp.:
837 – 839
Hyper- and Normo- Calcemic Dogs with Chronic Renal Failure: Relations of Serum PTH and Calcitriol to PTG Ca++ Set-Point
pp.:
839 – 841
Dietary Intake and Status of Vitamin D and Calcium in Patients with Chronic Renal Failure (CRF) Treated by Haemodialysis (HD) at home
pp.:
841 – 843
Osteocalcin (OC) in Adolescents with Advanced Renal Failure
pp.:
843 – 845
Osteoporosis
pp.:
845 – 847
Long-Term Calcitriol Treatment in Post-Menopausal Osteoporosis: Follow-Up of two Hundred Patients
pp.:
847 – 857
Osteoporosis and Vitamin D Metabolism: The State of our Knowledge as of 1988
pp.:
857 – 866
The Rationale for Calcitriol Therapy in Osteoporosis
pp.:
866 – 876
Calcitriol Therapy in the Management of Osteoporosis
pp.:
876 – 878
Alfacalcidol in Prednisone Treatment: Effect on Bone Mineral Content in Lumbar Spine and Femur
pp.:
878 – 880
Decrease of Plasma 1,25-Dihydroxyvitamin D3 (1,25(OH)2D3) and Loss of Spinal Bone Mass in Women During Treatment with GnRH Agonists
pp.:
880 – 882
Effect of 26,27-Hexafluoro-1,25-Dihydroxyvitamin D3 (F6-1,25(OH)2D3) on Osteoporosis Induced by Immobilization Combined with Ovariectomy in the Rats
pp.:
882 – 884
Some Biochemical Markers in Distal Fore-Arm and Hip Fractures
pp.:
884 – 886
The Short Term Effects of Alfacalcidol in Elderly Osteoporotic Women
pp.:
886 – 888
Calcitonin Secretion in Osteoporosis of Turner Syndrome
pp.:
888 – 890
Determinants of Calcium Malabsorption in Postmenopausal Osteoporosis
pp.:
890 – 893
Sarcoidosis
pp.:
893 – 895
Regulated Expression of the Sarcoid Macrophage 25-Hydroxyvitamin D-1-Hydroxylation Reaction
pp.:
895 – 897
Accentuated Transpleural Gradient of “Total” and “Free” 1,25-Dihydroxyvitamin D in Patients with Tuberculous Pleuritis
pp.:
897 – 899
The Effects of Ketoconazole and Metyrapone on Activated Alveolar Macrophages
pp.:
899 – 901
1,25(OH)2D3 Production by Lung T Lymphocytes from Tuberculosis Patients
pp.:
901 – 903
Cancer and Vitamin D
pp.:
903 – 905
Treatment of Myelodysplastic Syndrome and AML with 1α Hydroxyvitamin D3
pp.:
905 – 907
Nude Mouse Model (CAC-8) of Humoral Hypercalcemia of Malignancy (HHM) with Increased Serum Levels of 1,25-Dihydroxycholecalciferol (1,25(OH)2D): In Vivo and in Vitro Studies
pp.:
907 – 909
Effects of Treatment with the Bisphosphonate APD on 1,25-Dihydroxyvitamin D in Patients with Malignant Hypercalcaemia
pp.:
909 – 911
Effect of 1α-Hydroxyvitamin D3 on Growth of Nitrosomethylurea-Induced Rat Mammary Tumors
pp.:
911 – 913
Diabetes and Vitamin D
pp.:
913 – 915
Interaction between Vitamin D, Insulin and Diabetes Mellitus
pp.:
915 – 925
Endogenous Diabetes Decreases the Number of 1,25-Dihydroxyvitamin D3 Receptors in both Intestine and Kidney
pp.:
925 – 927
Plasma Concentrations of Vitamin D Metabolites in Newly Diagnosed Young Insulin-Dependent Diabetics before and after Insulin Treatment
pp.:
927 – 929
The Effect of Hypocalcemia and Vitamin D-Deficiency on Glucose Utilization in Piglets
pp.:
929 – 931
Vitamin D-Induced Increase in Calcium Content in Secretory Granules of B Cells Plays a Role in Recovery of Insulin Secretion in Vitamin D-Deficient Rats
pp.:
931 – 933
Increase in Insulin Response to Glucagon Following UV-B Irradiation in Healthy Adults
pp.:
933 – 937
Serum 1,25(OH)2D3 in the Elderly and Osteoporotic Subjects from Southern Italy. A Preliminary Report
pp.:
937 – 939
Gerontology and Vitamin D
pp.:
937 – 937
Effect of Age on the Rat Intestinal 1,25(OH)2D3 Receptor
pp.:
939 – 941
Effect of Age and 1,25(OH)2D3 on Calcium Uptake in Rat Duodenum Cells
pp.:
941 – 943
Low Serum Concentrations of 25-Hydroxyvitamin D, Selenium and Osteocalcin in Finnish Elderly Men
pp.:
943 – 945
Response of the Serum Level of 1,25(OH)2D to Restriction of Dietary Phosphorus: Effect of Advanced Age
pp.:
945 – 947
Intestinal End-Organ Resistance to 1,25-Dihydroxyvitamin D Stimulation of Calcium Absorption in the Senescent Rat
pp.:
947 – 949
Pregnancy/Neonatology
pp.:
949 – 951
Serum Vitamin D, 25-OHD, and 1,25(OH)2D, Bone Mineral Content (BMC) and Mineral Homeostasis in Premature Infants Fed High Mineral Premature Formula
pp.:
951 – 953
Normal Plasma 1,25(OH)2D3 in a Breast Fed Premature Infant with Early Hypophosphatemic Rickets
pp.:
953 – 955
Changes in 1,25-Dihydroxyvitamin D3 Receptor (1,25 DR) Content of Rat Mammary Gland During Pregnancy and Lactation
pp.:
955 – 957
Concentration of Vitamin D Metabolites in Amniotic Fluid and Serum During Pregnancy
pp.:
957 – 959
1,25(OH)2D3 and Ostoecalcin Concentrations in Fetuses and Neonates from Rats Fed two Different Calcium-Phosphate Diets
pp.:
959 – 961
Intact PTH and Vitamin D Metabolites in Early Neonatal Hypocalcemia
pp.:
961 – 963
Other Clinical Topics
pp.:
963 – 965
Vitamin D and the Skin: Site of Synthesis, Target Tissue, and New Therapeutic Approach for Psoriasis
pp.:
965 – 975
Inborn Errors in Vitamin D Metabolism – Their Contribution to the Understanding of Vitamin D Metabolism
pp.:
975 – 988
Vitamin D and Human Antituberculosis Immunity
pp.:
988 – 998
Successful Treatment of Psoriasis with Topical Application of the Active Vitamin D3 Analog, 1α,24-Dihydroxycholecalciferol (TV-02)
pp.:
998 – 1008
Evidence that Alteration of the Vitamin D-Endocrine System in Obesity Results from Vitamin D Deficiency
pp.:
1008 – 1016
Abnormal 1,25(OH)2D3 Receptor Relation of Parathyroid Gland in Lead Intoxication
pp.:
1016 – 1017
Hypocalcemia and Decreased 1,25(OH)2D Blood Levels in Septic Patients
pp.:
1017 – 1019
Serum Vitamin D and Calcium Metabolism in Tuberculosis Patients Resident in two Tropical Environments
pp.:
1019 – 1021
Abnormal Vitamin D Metabolism in Primary Aldosteronism and Experimental Mineralocorticoid Excess
pp.:
1021 – 1023
Vitamin D Metabolites and Intact PTH in Spasmophilia
pp.:
1023 – 1025
Vitamin D Status in Patients with Cystic Fibrosis: Seasonal Variations and the Importance of Vitamin D Supplementation:
pp.:
1025 – 1027
An Epidemiological Association between Vitamin D Deficiency and Tuberculosis
pp.:
1027 – 1029
Conversion of 1α-OHD3 into 1,25(OH)2D3 in Normal Subjects, Cirrhotic Patients and Postmenopausal Osteoporotic Women
pp.:
1029 – 1031
The Role of 1,25-Dihydroxyvitamin D in Salt Sensitive Essential Hypertension: Effects of Calcium Channel Blockade
pp.:
1031 – 1033
Vitamin D3 Induced Glycolic Aciduria in an Experimental Stone Model A. Halabe, N. L. M. Wong, L. Hagen, H. Hughes, R. A. L. Sutton
pp.:
1033 – 1035
Vitamin D Metabolism in Benign Transient Hyperphosphatasaemia
pp.:
1035 – 1037
Serum Calcium can Modulate the Production of 1,25-Dihydroxyvitamin D Independently of PTH in Man
pp.:
1037 – 1039
Age-Dependent Changes of Vitamin D Status and 1,25(OH)2D3 Receptor Expression in Spontaneously Hypertensive (SH) Rats
pp.:
1039 – 1041
Behavioral Changes in Chronically D-Hypervitaminotic Animals
pp.:
1041 – 1047
1,25-Dihydroxyvitamin D3 is an Effective Therapeutic Agent for the Treatment of Psoriasis Vulgaris and Erythroderma Psoriasis
pp.:
1047 – 1049
Vitamin D, Calcium and Hypertension
pp.:
1049 – 1053
Dietary Vitamin D Level and Mineral (P, Ca) Absorption in Pigs Fed Phytic P Diets
pp.:
1053 – 1055
Effect of Active Vitamin D3 on Enterocytes and Fatty Acid Binding Substance in Microsomal Fraction of Intestinal Mucosa of Rats
pp.:
1055 – 1057
Vitamin D Therapy in Renal Failure – Challenges and Problems for the Future
pp.:
1057 – 1061
Synthesis of 24R,25-Dihydroxyvitamin D3 from Vitamin D2 and Study on Inclusion Complexes of Vitamin D Derivatives with β-Cyclodextrin
pp.:
1061 – 1065
Author Index
pp.:
1065 – 1073
Key Word Index
pp.:
1073 – 1107
Cell Line Index
pp.:
1107 – 1109
Vitamin D Workshop Zoo
pp.:
1109 – 1111
Summary of the Dates and Locations of the Seven Vitamin D Workshops
pp.:
1111 – 1112
Vitamin D Workshop Logo
pp.:
1112 – 1117